Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study

Hepatology

Volumn 32, Issue 1, 2000, Pages 91-96

  Wiese, Manfred ^a   Berr, Frieder ^b   Lafrenz, Michael ^b   Porst, Heiner ^b   Oesen, Ute ^b  

^a Klinikum St Georg   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; RHESUS D ANTIBODY;

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; DISEASE COURSE; DRUG CONTAMINATION; FEMALE; FOLLOW UP; GERMANY; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SUPERINFECTION;

EID: 0034235962     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.8169     Document Type: Article

References (39)

1. 1. National Institutes of Health Consensus Development Conference Panel Statement. Management of Hepatitis C. HEPATOLOGY 1997;26(Suppl 1):2S-10S.
2. 2. EASL International Consensus Conference on Hepatitis C. Consensus Statement. J Hepatol 1999;30:956-961.
3. 3. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
4. 4. Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997;112:651-655.
5. 5. Seeff LB. Natural history of hepatitis C. HEPATOLOGY 1997;26(Suppl 1):21S-28S.
6. 6. Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000;132:105-111.
7. 7. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-1213.
8. 8. Kenny-Walsh E, for the Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 1999;340:1228-1233.
9. 9. Bericht der Staatlichen Hygiene-Inspektion vom 26. November 1979, Ministerium für Gesundheitswesen der DDR. In: Deutsche Bundestag; Bundesdrucksache 13/2732 vom 24.10.1995. Bonn: Bundesanzeiger Verlagsgesellschaft mbH 1995.
10. 10. Höhne M, Schreier E, Roggendorf M. Sequence variability in the env-encoding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol 1994;137:25-34.
11. 11. Wiese M, Haupt R, Kirsch W D. Zum gegenwärtigen Erkenntnisstand bei Non-A-Non-B Hepatitis (NANBH) - Eigene Ergebnisse zu Klinik und Epidemiologie. Z Klin Med 1988;43:759-764.
12. 12. Wiese M. NonA-nonB-Hepatitis. Virushepatitis C. Stuttgart: Fischer, 1991.
13. 13. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
14. 14. Bronowicki JP, Vetter D, Uhl G, Hudziak H, Vetter JM, Doffoel M. Lymphocyte reactivity to hepatitis C virus antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 1997;176:518-522.
15. 15. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. Hepatitis C virus specific cytolytic T lymphocytes and T helper responses in seronegative persons. J Infect Dis 1997;176:859-866.
16. 16. Sachithanandan S, Fielding JF. Jaundice at onset signifies a good prognosis in anti-D-associated HCV infection. Europ J Gastroenterol Hepatol 1997;9:77-79.
17. 17. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. HEPATOLOGY 1997;25:1250-1254.
18. 18. Gavier B, Martinez-Gonzalez MA, Riezu-Boj JI, Lasarte JJ, Garcia N, Civeira MP, Prieto J. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology 1997;113:1647-53.
19. 19. Hopf U, Möller B, Küther D, Stemerowicz R, Lobeck H, Lüdtke-Handjery A, Walter E, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus. J Hepatol 1990;10:69-76.
20. 20. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
21. 21. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol 1992;16:273-281.
22. 22. Koretz FL, Abbey H, Coleman E, Gitnick G. Non-A, non-B posttransfusion hepatitis: looking back into the second decade. Ann Intern Med 1993;119:110-115.
23. 23. Mattson L, Sonnerborg A, Weiland O. Outcome of acute asymptomatic non-A, non-B hepatitis: a thirteen year follow-up study of hepatitis C virus markers. Liver 1993;13:274-278.
24. 24. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
25. 25. Seeff LB, Hollinger B, Alter HJ. Long-term morbidity of post-transfusion hepatitis C [Abstract]. HEPATOLOGY 1998;28(Suppl):407A.
26. 26. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Akahane Y, Nishioka K, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. HEPATOLOGY 1990;12:671-675.
27. 27. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural history of chronic hepatitis C. Am J Gastroenterol 1993;88:240-243.
28. 28. Roberts JM, Searle JW, Cooksley WEG. Histological patterns of prolonged hepatitis C virus infection. Gastroenterol Jpn 1993;28:901-905.
29. 29. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
30. 30. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.
31. 31. Serfaty L, Aumaitre H, Chazouillères O, Bonnand AM, Rosmorduc O, Poupon RE, Poupon R. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. HEPATOLOGY 1998;27:1435-1440.
32. 32. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. HEPATOLOGY 1998;28:1687-1695.
33. 33. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
34. 34. Björkander J, Cunningham-Rundles C, Lundin P, Olsson R, Söderström R, Hanson LA. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988;17:93-105.
35. 35. Björo K, Fröland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-1611.
36. 36. Conry-Cantilena C, Van Raden M, Gibble J, Melpolder J, Shakil AO, Viladomiou L, Cheung L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-1696.
37. 37. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, Lau D, et al. Hepatitis C in asymptomatic blood donors. HEPATOLOGY 1997;26(Suppl 1):29S-33S.
38. 38. Vogt M, Lang T, Frösner G, Klingler Ch, Sendl AF, Zeller A, Wiebecke B, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood donor screening. N Engl J Med 1999;341:866-870.
39. 39. Yamakawa Y, Sata M, Suzuki H, Nogushi S, Tanikawa K. Higher elimination rate of hepatitis C virus among women. J Viral Hepatitis 1996;3:317-332.